These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1678917)

  • 61. Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988.
    Am J Med; 1989 Aug; 87(2A):1S-66S. PubMed ID: 2569821
    [No Abstract]   [Full Text] [Related]  

  • 62. First European review of terazosin. Proceedings of a symposium. Reykjavik, Iceland, 29th-31st May 1987.
    Br J Clin Pract Suppl; 1987 Dec; 54():1-69. PubMed ID: 2905157
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical applications of alpha 1-receptor blockade: terazosin in the management of hypertension. Introduction.
    Rosenthal J; Kyncl JJ
    J Clin Pharmacol; 1993 Sep; 33(9):866-7. PubMed ID: 7901240
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical model for antihypertensive therapy in the 1990s: the role of alpha1 blockade. Proceedings of a symposium. Irving, Texas, November 8-10, 1990.
    Am Heart J; 1991 Sep; 122(3 Pt 2):885-942. PubMed ID: 1678917
    [No Abstract]   [Full Text] [Related]  

  • 65. Alpha 1-blockade in the management of hypertension.
    Horky K
    J Clin Pharmacol; 1993 Sep; 33(9):874-8. PubMed ID: 7901241
    [No Abstract]   [Full Text] [Related]  

  • 66. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM
    Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
    Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
    J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Terazosin].
    Schäfers RF; Michel MC
    Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
    [No Abstract]   [Full Text] [Related]  

  • 69. Alpha-blocker therapy of hypertension. An unfulfilled promise.
    Khoury AF; Kaplan NM
    JAMA; 1991 Jul; 266(3):394-8. PubMed ID: 1676077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
    Warren JB; Dollery CT
    J Hypertens Suppl; 1988 Dec; 6(2):S43-9. PubMed ID: 2906700
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.